|
PGAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.165960E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.386200E-01 |
| Normal-vs-Stage2 |
4.816300E-02 |
| Normal-vs-Stage3 |
4.980400E-02 |
| Normal-vs-Stage4 |
3.840400E-04 |
| Stage1-vs-Stage2 |
1.961020E-01 |
| Stage1-vs-Stage3 |
1.569980E-01 |
| Stage1-vs-Stage4 |
3.242400E-04 |
| Stage2-vs-Stage3 |
7.883800E-01 |
| Stage2-vs-Stage4 |
2.428600E-01 |
| Stage3-vs-Stage4 |
7.440200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.012100E-02 |
| Normal-vs-AfricanAmerican |
3.203400E-01 |
| Normal-vs-Asian |
1.100640E-01 |
| Caucasian-vs-AfricanAmerican |
9.033000E-01 |
| Caucasian-vs-Asian |
7.871400E-01 |
| AfricanAmerican-vs-Asian |
7.699800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.452000E-02 |
| Normal-vs-Female |
1.482020E-01 |
| Male-vs-Female |
5.089800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.255000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.584200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.634200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.352560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.911900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.026100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.289010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.673800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.524600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.647600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.119820E-02 |
| Classical-VS-Follicular |
3.700400E-01 |
| Classical-VS-Other |
9.090600E-01 |
| Classical-VS-Normal |
3.105400E-01 |
| Tall-VS-Follicular |
1.365410E-01 |
| Tall-VS-Other |
4.754000E-01 |
| Tall-VS-Normal |
6.501500E-03 |
| Follicular-VS-Other |
8.531400E-01 |
| Follicular-VS-Normal |
1.050220E-01 |
| Other-VS-Normal |
5.645400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.976400E-02 |
| Normal-vs-N1 |
7.042000E-02 |
| N0-vs-N1 |
7.498800E-01 |
|
|
